Caliway Biopharmaceuticals Co Ltd
TWSE:6919
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Caliway Biopharmaceuticals Co Ltd
TWSE:6919
|
TW |
|
A
|
Ability Enterprise Co Ltd
TWSE:2374
|
TW |
Shareholder Yield
Current shareholder yield for Caliway Biopharmaceuticals Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
Price
Caliway Biopharmaceuticals Co Ltd
| Average Annual Return | 141.88% |
| Standard Deviation of Annual Returns | 132.31% |
| Max Drawdown | -100% |
| Market Capitalization | 132.9B TWD |
| Shares Outstanding | 1 553 880 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Caliway Biopharmaceuticals Co Ltd's latest stock split occurred on Jul 14, 2025
The company executed a 10-for-1 stock split, meaning that for every share held, investors received 10 new shares.
Before the split, Caliway Biopharmaceuticals Co Ltd traded at 121.5 per share. Afterward, the share price was about 121.5.
The adjusted shares began trading on Jul 14, 2025. This was the only stock split in Caliway Biopharmaceuticals Co Ltd's history.
